SCHEMBL13298474

SCHEMBL13298474

c1ccc([SiH2]c2ccc3c(-c4ccncc4)c4ccccc4c(-c4ccncc4)c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IMPDH2 P12268 5/20 0.41
▸ NOTUM Q6P988 1/20 0.39
▸ MAPK14 Q16539 4/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MAPK1 P28482 2/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ MKNK1 Q9BUB5 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ APOBEC3G Q9HC16 1/20 0.33
▸ ESR1 P03372 1/20 0.33
▸ ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298462 0.98 NOTUM (0.42) IMPDH2NOTUMMAPK14ALDH1A1MAPT
SCHEMBL13298473 0.98 NOTUM (0.42) IMPDH2NOTUMMAPK14ALDH1A1MAPT
SCHEMBL13298469 0.89 MAPK10 (0.42) MAPK14ALDH1A1MAPTKDM4EESR1
SCHEMBL13298467 0.89 MAPK10 (0.42) MAPK14ALDH1A1MAPTKDM4EESR1
SCHEMBL13298461 0.88 ACHE (0.37) ALDH1A1MAPTKDM4EMEN1LMNA
SCHEMBL13298464 0.88 CYP11B1 (0.40) IMPDH2NOTUMALDH1A1MAPTKDM4E
SCHEMBL13298465 0.88 KDM4E (0.41) IMPDH2MAPK14ALDH1A1MAPTKDM4E
SCHEMBL13298468 0.88 KDM4E (0.41) IMPDH2MAPK14ALDH1A1MAPTKDM4E
SCHEMBL13298466 0.88 CYP11B1 (0.40) IMPDH2NOTUMALDH1A1MAPTKDM4E
SCHEMBL13298459 0.77 ESR1 (0.40) ALDH1A1KDM4EMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 IMPDH2 1093/4885NOTUM 654/4885MAPK14 2274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback